Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

SoftBank is looking to invest up to $300 million in Wag, the dog-walking app

It shows how SoftBank has affected funding amounts in Silicon Valley.

SoftBank CEO Masayoshi Son
SoftBank CEO Masayoshi Son
SoftBank CEO Masayoshi Son
Koki Nagahama / Getty

SoftBank has been in talks to invest as much as $300 million in the dog-walking app Wag, according to people familiar with the conversations.

It’s a concrete example of how SoftBank is transforming financing in tech.

Wag was originally looking to raise $100 million in this latest round, the sources tell Recode, but it ballooned to the $300 million neighborhood when SoftBank expressed interest. One person said Wag had already received an investment offer from a top venture capital firm on the $100 million round before SoftBank came in.

The startup had already raised $40 million just eight months ago — an investment the company said would allow it to expand into new cities. It’s unclear why the company would need to raise so much more money less than a year after a previous fundraising round.

The SoftBank deal has not yet closed, and so the total investment size from SoftBank’s Vision Fund could change. The valuations could not be learned. And the talks could, as always, fall apart.

But investors across Silicon Valley have been humming about the round for weeks since it shows the power of SoftBank, led by CEO Masayoshi Son, to reshape the funding landscape and amounts in Silicon Valley. SoftBank has been behind almost all of the biggest financings in Silicon Valley, from Uber to WeWork to DoorDash just last month.

SoftBank and Wag both declined to comment. Axios reported on the SoftBank talks.

The dog-walking company, in a fierce competition with the similar service Rover, just last April raised around $40 million in a deal that, including the cash, valued it at around $200 million, according to PitchBook. Previous investors include General Catalyst and Sherpa Capital.

Wag functions as a marketplace that pairs dog owners with available walkers in their neighborhood. The Los Angeles-based company, run by Josh Viner, was founded in 2014. The company has also been mired in a drama involving a missing dog, sparking concerns over the service’s safety.


This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh